【英文論文】

1. Oyama M, Okada K, Masuda M, Shimizu Y, Yokoyama K, Uzawa A, Kawaguchi N, Ikeguchi R, Hoshino Y, Hatano T, Ozawa Y, Nakahara J, Aizawa H, Kitagawa K, Hattori N, Kuwabara S, Murai H, Suzuki S: Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis. Ther Adv Neurol Disord 2020 Mar 18; 13: 1-9. doi: 10.1177/1756286420904207 [IF 6.570]
2. Hamaguchi T, Sakai K, Kobayashi A, Kitamoto T, Ae R, Nakamura Y, Sanjo N, Arai K, Koide M, Katada F, Harada M, Murai H, Murayama S, Tsukamoto T, Mizusawa H, Yamada M: Characterization of sporadic Creutzfeldt-Jakob disease and history of neurosurgery to identify potential iatrogenic cases. Emerg Infect Dis 2020 Jun; 26: 1140-1146. doi: 10.3201/eid2606.181969 [IF 6.883]
3. Jacob S, Murai H, Utsugisawa K, Nowak RJ, Wiendl H, Fujita KP, O’Brien F, Howard JF: Response to eculizumab in patients with myasthenia gravis recently treated with chronic IVIg: a subgroup analysis of REGAIN and its open-label extension study. Ther Adv Neurol Disord 2020 May 6; 13: 1-8. doi: 10.1177/1756286420911784 [IF 6.570]
4. Sakai K, Hamaguchi T, Sanjo N, Murai H, Iwasaki Y, Hamano T, Honma M, Noguchi-Shinohara M, Nozaki I, Nakamura Y, Kitamoto T, Harada M, Mizusawa H, Yamada M: Diffusion-weighted magnetic resonance imaging in dura mater graft-associated Creutzfeldt-Jakob disease. J Neurol Sci 2020 Aug 13; 418:117094. doi: 10.1016/j.jns.2020.117094. [IF 3.181]
5. Hamaguchi T, Sanjo N, Ae R, Nakamura Y, Kitamoto T, Sakai K, Takao M, Murayama S, Iwasaki Y, Satoh K, Murai H, Harada M, Tsukamoto T, Mizusawa H, Yamada M. MM2 type sporadic Creutzfeldt-Jakob disease: new diagnostic criteria for MM2-cortical type. J Neurol Neurosurg Psychiatry 2020 Nov; 91: 1158-1165. doi: 10.1136/jnnp-2020-323231 [IF 10.283]
6. Orimo K, Iwata NK, Kawai M, Nakajima H, Takeda K, Murai H, Goto J: A case of Anti-LGI1 antibody encephalitis developing immunoglobulin responsive orthostatic hypotension after remission. Int Med 2020 Oct 14. doi: 10.2169/internalmedicine.5359-20 [IF 1.271]
7. Utsugisawa K, Nagane Y, Uzawa A, Murai H, Imai T, Suzuki S: Health‐related quality of life and treatment strategies in myasthenia gravis. Clin Exp Neuroimmunol 2020; 11: 209-217
8. Suzuki S, Nagane Y, Uzawa A, Imai T, Murai H, Nakahara J, Utsugisawa K: Anti‐striational antibodies: Expanding their clinical significance. Clin Exp Neuroimmunol 2020; 11: 218-224
9. Murai H, Utsugisawa K, Motomura M, Suzuki S, Imai T: Seeking ideal clinical guidelines for myasthenia gravis. Clin Exp Neuroimmunol 2020; 11: 225-229
10. Une H, Matsuse D, Uehara T, Kikuchi Y, Inamizu S, Yamasaki R, Tobimatsu S, Shibasaki H, Kira JI: Branchial myorhythmia in a case of systemic lupus erythematosus. J Neurol Sci. 2020 Jan 15; 408: 116501. doi: 10.1016/j.jns.2019.116501 [IF 3.181]
11. Matsubara T, Hironaga N, Uehara T, Chatani H, Tobimatsu S, Kishida K: A novel method for extracting interictal epileptiform discharges in multi-channel MEG: Use of fractional type of blind source separation. Clin Neurophysiol 2020 Feb; 131(2): 425-436.  doi:  10.1016/j.clinph.2019.11.032 [IF 3.708]
12. Yoshimura M, Uehara T, Tanaka E, Okadome T, Yamaguchi T, Maeda Y, Isobe N, Matsushita T, Yamasaki R, Kira JI: Double positivity for anti-N-methyl-d-aspartate receptor and anti-aquaporin-4 antibodies in a patient presenting with hypersomnolence, personality change, and reduced spontaneity. Clinical and Experimental Neuroimmunology 2020; 11(S1): 53-56. Doi: 10.1111/cen3.12571
13. Inamizu S, Yamada E, Ogata K, Uehara T, Kira JI, Tobimatsu S: Neuromagnetic correlates of hemispheric specialization for face and word recognition. Neurosci Res 2020 Jul; 156: 108-116. doi: 10.1016/j.neures.2019.11.006 [IF 3.322]